1. Home
  2. LSAK vs ZVRA Comparison

LSAK vs ZVRA Comparison

Compare LSAK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • ZVRA
  • Stock Information
  • Founded
  • LSAK 1997
  • ZVRA 2006
  • Country
  • LSAK South Africa
  • ZVRA United States
  • Employees
  • LSAK N/A
  • ZVRA N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSAK Finance
  • ZVRA Health Care
  • Exchange
  • LSAK Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • LSAK 408.0M
  • ZVRA 433.5M
  • IPO Year
  • LSAK N/A
  • ZVRA 2015
  • Fundamental
  • Price
  • LSAK $5.00
  • ZVRA $7.32
  • Analyst Decision
  • LSAK
  • ZVRA Strong Buy
  • Analyst Count
  • LSAK 0
  • ZVRA 8
  • Target Price
  • LSAK N/A
  • ZVRA $22.29
  • AVG Volume (30 Days)
  • LSAK 33.5K
  • ZVRA 504.8K
  • Earning Date
  • LSAK 05-07-2025
  • ZVRA 03-11-2025
  • Dividend Yield
  • LSAK N/A
  • ZVRA N/A
  • EPS Growth
  • LSAK N/A
  • ZVRA N/A
  • EPS
  • LSAK N/A
  • ZVRA N/A
  • Revenue
  • LSAK $576,604,000.00
  • ZVRA $23,612,000.00
  • Revenue This Year
  • LSAK $0.04
  • ZVRA $281.10
  • Revenue Next Year
  • LSAK $1.74
  • ZVRA $97.98
  • P/E Ratio
  • LSAK N/A
  • ZVRA N/A
  • Revenue Growth
  • LSAK 5.39
  • ZVRA N/A
  • 52 Week Low
  • LSAK $3.83
  • ZVRA $4.20
  • 52 Week High
  • LSAK $5.60
  • ZVRA $9.76
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 56.02
  • ZVRA 37.45
  • Support Level
  • LSAK $4.51
  • ZVRA $7.78
  • Resistance Level
  • LSAK $5.10
  • ZVRA $8.33
  • Average True Range (ATR)
  • LSAK 0.26
  • ZVRA 0.35
  • MACD
  • LSAK 0.04
  • ZVRA -0.07
  • Stochastic Oscillator
  • LSAK 86.67
  • ZVRA 4.88

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: